EPIRUS Biopharmaceuticals, Inc.
EPIRUS Biopharmaceuticals, Inc. (EPRSQ) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · EPRSQ · as of Jun 9, 2026
Key Statistics
Explore EPIRUS Biopharmaceuticals, Inc. Data
eprsq stock data · financialsCompetitors & Peers
eprsq competitorsEPRSQ
ALNAQ
ARTH
GNRS
GWHP
INTPStock Performance
Full HistoryAbout EPIRUS Biopharmaceuticals, Inc.
EPIRUS Biopharmaceuticals, Inc. was a global pharmaceutical firm dedicated to the research, development, manufacturing, and commercialization of biosimilar therapeutics. Its primary experimental compo…
what is epirus biopharmaceuticals, inc. · eprsq stock overview · epirus biopharmaceuticals, inc. company profile · who is epirus biopharmaceuticals, inc. ceo · eprsq OTC · epirus biopharmaceuticals, inc. headquarters · epirus biopharmaceuticals, inc. business segments
About Stock Overview & Key Data
EPIRUS Biopharmaceuticals, Inc. (EPRSQ) is a Healthcare company in the Biotechnology industry, listed on OTC since Nov 9, 2005. As of the latest trading session, EPRSQ stock price is $0.00, with a market capitalization of $1,571. The stock has returned -99.00% over the past 12 months and -99.00% year-to-date.
Frequently Asked Questions
As of the latest trading session, EPIRUS Biopharmaceuticals, Inc. (EPRSQ) stock price is $0.00. The stock is traded on OTC under the ticker symbol EPRSQ. The 52-week range is $1.00 – $6.00.